Pliant Therapeutics (PLRX) Short Interest Ratio & Short Volume → With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (From Stocks News) (Ad) Free PLRX Stock Alerts $15.36 +1.22 (+8.63%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Pliant Therapeutics Short Interest DataCurrent Short Volume7,550,000 sharesPrevious Short Volume7,620,000 sharesChange Vs. Previous Month-0.92%Dollar Volume Sold Short$89.24 millionShort Interest Ratio / Days to Cover21.8Last Record DateApril 30, 2024Outstanding Shares60,330,000 sharesPercentage of Shares Shorted12.51%Today's Trading Volume1,269,935 sharesAverage Trading Volume399,712 sharesToday's Volume Vs. Average318% Short Selling Pliant Therapeutics ? Sign up to receive the latest short interest report for Pliant Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPLRX Short Interest Over TimePLRX Days to Cover Over TimePLRX Percentage of Float Shorted Over Time Ad Weiss Ratings[URGENT] DO NOT Touch These AI Stocks!Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond Pliant Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20247,550,000 shares $89.24 million -0.9%N/A21.8 $11.82 4/15/20247,620,000 shares $103.25 million +2.1%N/A21.1 $13.55 3/31/20247,460,000 shares $111.15 million +6.6%N/A18.9 $14.90 3/15/20247,000,000 shares $106.33 million +2.0%N/A16.8 $15.19 2/29/20246,860,000 shares $108.87 million +1.5%N/A15.7 $15.87 2/15/20246,760,000 shares $113.57 million +8.9%N/A15.5 $16.80 Get the Latest News and Ratings for PLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pliant Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,210,000 shares $111.28 million -2.5%N/A13.4 $17.92 1/15/20246,370,000 shares $114.02 million +0.8%N/A13.7 $17.90 12/31/20236,320,000 shares $114.46 million -0.6%N/A13.3 $18.11 12/15/20236,360,000 shares $106.59 million -1.6%N/A11.3 $16.76 11/30/20236,460,000 shares $89.73 million -1.1%N/A11.2 $13.89 11/15/20236,530,000 shares $88.81 million +3.0%N/A11.5 $13.60 10/31/20236,340,000 shares $93.01 million -2.2%N/A10.8 $14.67 10/15/20236,480,000 shares $98.82 million -6.2%N/A10.1 $15.25 9/30/20236,910,000 shares $119.82 million +9.5%N/A10.7 $17.34 9/15/20236,310,000 shares $101.02 million +4.3%N/A8.2 $16.01 8/31/20236,050,000 shares $102.12 million -2.4%N/A7.8 $16.88 8/15/20236,200,000 shares $111.17 million +5.3%N/A7.9 $17.93 7/31/20235,890,000 shares $105.08 million -1.7%N/A7 $17.84 7/15/20235,990,000 shares $109.62 million -6.0%N/A6.5 $18.30 6/30/20236,370,000 shares $115.42 million +12.5%N/A6.7 $18.12 6/15/20235,660,000 shares $132.39 million -4.9%N/A6.5 $23.39 5/31/20235,950,000 shares $128.70 million -3.4%N/A8.3 $21.63 5/15/20236,160,000 shares $137.55 million +48.4%N/A8.7 $22.33 4/30/20234,150,000 shares $117.24 million +7.8%N/A6.3 $28.25 4/15/20233,850,000 shares $102.03 million +7.2%N/A4.6 $26.50 3/31/20233,590,000 shares $95.49 million +26.4%N/A4.4 $26.60 3/15/20232,840,000 shares $78.19 million +2.5%N/A3.6 $27.53 2/28/20232,770,000 shares $88.25 million +10.8%N/A3.6 $31.86 2/15/20232,500,000 shares $78.28 million -7.4%N/A3.2 $31.31 1/31/20232,700,000 shares $94.61 million -18.9%N/A3.5 $35.04 1/15/20233,330,000 shares $78.06 million -10.0%N/A4.7 $23.44 12/30/20223,700,000 shares $71.52 million +26.3%N/A9.5 $19.33 12/15/20222,930,000 shares $56.90 million -10.7%N/A7.3 $19.42 11/30/20223,280,000 shares $60.29 million -12.8%N/A7.2 $18.38 11/15/20223,760,000 shares $81.52 million +1.6%N/A9.1 $21.68 10/31/20223,700,000 shares $92.02 million -1.9%N/A8.7 $24.87 10/15/20223,770,000 shares $85.13 million +9.6%N/A7.9 $22.58 9/30/20223,440,000 shares $71.86 million +8.9%N/A1.7 $20.89 9/15/20223,160,000 shares $75.46 million +4.6%N/A1.5 $23.88[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond PLRX Short Interest - Frequently Asked Questions What is Pliant Therapeutics' current short interest? Short interest is the volume of Pliant Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 7,550,000 shares of PLRX short. Learn More on Pliant Therapeutics' current short interest. What is a good short interest ratio for Pliant Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PLRX shares currently have a short interest ratio of 22.0. Learn More on Pliant Therapeutics's short interest ratio. Is Pliant Therapeutics' short interest increasing or decreasing? Pliant Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 7,550,000 shares, a decline of 0.9% from the previous total of 7,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pliant Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Pliant Therapeutics: Tango Therapeutics, Inc. (19.84%), Evolus, Inc. (9.69%), Longboard Pharmaceuticals, Inc. (13.02%), Zentalis Pharmaceuticals, Inc. (24.64%), ALX Oncology Holdings Inc. (11.46%), Sage Therapeutics, Inc. (16.60%), 89bio, Inc. (10.93%), Praxis Precision Medicines, Inc. (5.06%), OPKO Health, Inc. (26.42%), Y-mAbs Therapeutics, Inc. (7.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Pliant Therapeutics stock? Short selling PLRX is an investing strategy that aims to generate trading profit from Pliant Therapeutics as its price is falling. PLRX shares are trading up $1.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pliant Therapeutics? A short squeeze for Pliant Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PLRX, which in turn drives the price of the stock up even further. How often is Pliant Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PLRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Tango Therapeutics Short Interest Evolus Short Interest Longboard Pharmaceuticals Short Interest Zentalis Pharmaceuticals Short Interest ALX Oncology Short Interest Sage Therapeutics Short Interest 89bio Short Interest Praxis Precision Medicines Short Interest OPKO Health Short Interest Y-mAbs Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PLRX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsGold Set to EXPLODE!Gold Safe Exchange"The Biggest Drug Ever" Is ComingBehind the MarketsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders